11/19
01:22 pm
snoa
Sonoma Pharmaceuticals (NASDAQ:SNOA) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Sonoma Pharmaceuticals (NASDAQ:SNOA) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/13
08:41 am
snoa
National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced [Yahoo! Finance]
Medium
Report
National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced [Yahoo! Finance]